Chardan Capital reissued their buy rating on shares of Ocular Therapeutix (NASDAQ:OCUL – Free Report) in a report published on Wednesday,Benzinga reports. The firm currently has a $23.00 target price on the biopharmaceutical company’s stock. Several other equities research analysts also recently weighed in on the company. HC Wainwright reaffirmed a “buy” rating and set […]

Chardan Capital restated their buy rating on shares of Kodiak AI (NASDAQ:KDK – Free Report) in a research report released on Wednesday,Benzinga reports. They currently have a $12.00 price target on the stock. A number of other equities analysts also recently commented on KDK. Wall Street Zen downgraded shares of Kodiak AI from a “sell” […]